Evaluation of percutaneous absorption of naproxen from different liposomal formulations

Journal of Pharmaceutical Sciences

Volumn 99, Issue 6, 2010, Pages 2819-2829

  Puglia, Carmelo ^a   Bonina, Francesco ^a   Rizza, Luisa ^a   Cortesi, Rita ^b   Merlotti, Elena ^b   Drechsler, Markus ^c   Mariani, Paolo ^d   Contado, Catia ^b   Ravani, Laura ^b   Esposito, Elisabetta ^b  

^a UNIVERSITY OF CATANIA   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

^c UNIVERSITY OF BAYREUTH   (Germany)

^d UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

Ceramide III and cholesterol sulphate; Liposomes; Naproxen; Palmitic acid; Skin; Tape stripping

Indexed keywords

CARBOMER; NANOPARTICLE; NAPROXEN; PHOSPHATIDYLCHOLINE; SKIN LIPID;

ADULT; ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; LIPOSOMAL DELIVERY; MALE; NORMAL HUMAN; PARTICLE SIZE; PHOTON CORRELATION SPECTROSCOPY; SKIN ABSORPTION; STRATUM CORNEUM; TRANSMISSION ELECTRON MICROSCOPY; X RAY DIFFRACTION;

EID: 77951568774     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22028     Document Type: Article

References (33)

1. Barry BW. 2002. Drug delivery routes in skin: A novel approach. Adv Drug Deliv Rev 54:S31-S40.
2. Kirjavainen M, Urtti A, Jääskeläinen I, Suhonen TM, Paronen P, Valjakka-Koskela R, Kiesvaara J, Mönkkönen J. 1996. Interaction of liposomes with human skin in vitro - The influence of lipid composition and structure. Biochim Biophys Acta 1304: 179-189. (Pubitemid 26426990)
3. Ogiso T, Yamaguchi T, Iwaki M, Tanino T, Miyake Y. 2001. Effect of positively and negatively charged liposomes on skin permeation of drugs. J Drug Target 9:49-59. (Pubitemid 32496450)
4. Puglia C, Esposito E, Menegatti E, Nastruzzi C, Rizza L, Cortesi R, Bonina F. 2005. Effect of charge and lipid concentration on in vivo percutaneous absorption of methyl nicotinate from liposomal vesicles. J Pharm Pharmacol 57:1169-1176. (Pubitemid 41391775)
5. Verma DD, Verma S, Blume G, Fahr A. 2003. Particle size of liposomes influences dermal delivery of substances into skin. Int J Pharm 258:141-151. (Pubitemid 36712878)
6. Perugini P, Genta I, Pavanetto F, Conti B, Scalia S, Baruffini A. 2000. Study on glycolic acid delivery by liposomes and microspheres. Int J Pharm 196:51-61. (Pubitemid 30089514)
7. Soltan Monem A, Ali FM, Ismail MW. 2000. Prolonged effect of liposomes encapsulating pilocarpine HCl in normal and glaumatous rabbits. Int J Pharm 198:29-38.
8. Glavas-Dodov M, Goracinova K, Mladenovska K, Fredro-Kumbaradzi E. 2002. Release profile of lidocaine HCl from topical liposomal gel formulation. Int J Pharm 242:381-384.
9. Blume A, Jansen M, Ghyczy M, Gareiss J. 1993. Interaction of phospholipid liposomes with lipid model mixtures for stratum corneum lipids. Int J Pharm 99:219-228. (Pubitemid 23312038)
10. Fang J, Hong C, Chiu W, Wang Y. 2001. Effect of liposomes and niosomes on skin permeation of enoxacin. Int J Pharm 219:61-72. (Pubitemid 32391365)
11. El Maghraby GMM, Williams AC, Barry BW. 1999. Skin delivery of estradiol from deformable and traditional liposomes: Mechanistic studies. J Pharm Pharmacol 51:1123-1134.
12. El Maghraby GMM, Barry BW, Williams AC. 2008. Liposomes and skin: From drug delivery to model membranes. Eur J Pharm Sci 34:203-222.
13. Fresno Contreras MJ, Jimenez Soriano MM, Ramirez Dieguez A. 2005. In vitro percutaneous absorption of all-trans retinoic acid applied in free form or encapsulated in stratum corneum lipid liposomes. Int J Pharm 297:134-145.
14. Puglia C, Trombetta D, Venuti V, Saija A, Bonina F. 2004. Evaluation of in vivo topical anti-inflammatory activity of indomethacin from liposomal vesicles (LUV). J Pharm Pharmacol 56:1225-1232. (Pubitemid 39368992)
15. Paolino D, Lucania G, Mardente D, Alhaique F, Fresta M. 2005. Ethosomes for skin delivery of ammonium glycyrrhizinate: In vitro percutaneous permeation through human skin and in vivo anti-inflammatory activity on human volunteers. J Control Rel 406:99-110.
16. Trotta M, Peira E, Debernardi F, Gallarate M. 2002. Elastic liposomes for skin delivery of dipotassium glycyrrhizinate. Int J Pharm 241:319-327. (Pubitemid 34718033)
17. Stuttgen G. 1988. The present status of anti-inflammatory agents in dermatology. Drugs 36:43-48. (Pubitemid 19175859)
18. Mayer LD, Hope MJ, Cullis PR. 1986. Vesicles of variable sizes produced by a rapid extrusion procedure. Biochim Biophys Acta 858:161-168.
19. Esposito E, Cortesi R, Drechsler M, Paccamiccio L, Mariani P, Contado C, Stellin E, Menegatti E, Bonina F, Puglia C. 2005. Cubosome dispersions as delivery systems for percutaneous administration of indomethacin. Pharm Res 22:2163-2173. (Pubitemid 41821596)
20. Levin S, Klausner E. 1995. Measurements of size distribution and density of pharmaceutical fat emulsions, using field-programmed sedimentation field-flow fractionation (SdFFF). Pharm Res 12:1218-1224.
21. Contado C, Blo G, Fagioli F, Dondi F, Beckett R. 1997. Characterization of River Po particles by sedimentation field-flow fractionation coupled to GFAAS and ICP-MS. Coll Surf A 120:47-59. (Pubitemid 27128040)
22. Kligman AM, Christophers E. 1963. Preparation of isolated sheets of human stratum corneum. Arch Dermatol 88:702-705.
23. Bronaugh RL, Stewart RF, Simon M. 1986. Methods for in vitro percutaneous absorption studies. VII: Use of excised human skin. J Pharm Sci 75:1049-1097. (Pubitemid 17216557)
24. Toitou E, Fabin B. 1988. Altered skin permeation of highly lipophilic molecule: Tetrahydrocannabinol. Int J Pharm 43:17-22. (Pubitemid 18097522)
25. Siewert M, Dressman J, Brown CK, Shah VP. FIP, AAPS. 2003. FIP/AAPS guidelines to dissolution/in vitro release testing of novel/special dosage forms. AAPS PharmSciTech 4:E7. (Pubitemid 36313473)
26. Wissing SA, Müller RH, Manthei L, Mayer C. 2004. Structural characterization of Q10-loaded solid lipid nanoparticles by NMR spectroscopy. Pharm Res 21:400-405. (Pubitemid 38338973)
27. Westesen K, Bunjes H, Koch MHJ. 1997. Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potential. J Control Rel 48:223-236. (Pubitemid 27401980)
28. Coderch L, Fonollosa J, de Pera M, Estelrich J, de La Maza A, Parra JL. 2000. Influence of cholesterol on liposome fluidity by EPR. Relationship with percutaneous absorption. J Control Rel 68:85-95. (Pubitemid 30407064)
29. du Plessis J, Ramachandran C, Weiner N, Muller DG. 1994. The influence of particle size of liposomes on the deposition of drug into skin. Int J Pharm 103:277-282.
30. Coderch L, de Pera M, Perez-Cullell N, Estelrich J, de la Maza A, Parra JL. 1999. The effect of liposomes on skin barrier structure. Skin Pharmacol Appl Skin Physiol 12:235-246. (Pubitemid 29401451)
31. Kato A, Ishibashi Y, Miyake Y. 1987. Effect of egg yolk lecithin on transdermal delivery of bunazosin hydrochloride. J Pharm Pharmacol 39:399-400. (Pubitemid 17119501)
32. Yokomizo Y, Sagitani H. 1996. Effects of phospholipids on the percutaneous penetration of indomethacin through the dorsal skin of the guinea pig, in vitro. 2. The effects of hydrophobic group in the phospholipids and a comparison with general enhancers. J Control Rel 42:37-46. (Pubitemid 26297874)
33. El Maghraby GM, Williams AC, Barry BW. 2006. Can drug bearing liposomes penetrate intact skin? J Pharm Pharmacol 58:415-429.